NicOx SA (COX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:NicOx SA (COX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011483
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NicOx SA (NicOx) is an pharmaceutical company that develops ophthalmic portfolio of therapies and diagnostic tools. The company offers ophthalmic products which include AdenoPlus, AzaSite, BromSite, Xailin, Vesneo, next generation NO-donors and Syk and JAK inhibitors, and others. It offers products in the therapeutic areas of NO-donating compounds, based on a strong research platform which creates new molecular entities. NicOx operates research centers in Italy that works on R&D studies covering various therapy areas such as cardiovascular, inflammation and ophthalmology. The company operates in Germany, the UK, France, Italy and the US. NicOx is headquartered in Nice, France.

NicOx SA (COX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NicOx SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NicOx SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NicOx SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NicOx SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
NicOx SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NicOx SA, Medical Equipment, Deal Details 10
Partnerships 10
Nicox Enters into Licensing Agreement with OptiMed for AdenoPlus and Xailin 10
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 11
Nicox and Re-Vana Therapeutics Enter into Research Agreement 12
NicOx Enters into Co-Marketing Agreement with Nitto Medic for AdenoPlus 13
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 14
Equity Offering 15
NicOx Raises USD31 Million in Private Placement of Shares 15
Nicox to Raise USD20 Million in Private Placement of Shares 16
Acquisition 17
NicOx Acquires Aciex Therapeutics 17
NicOx Acquires Doliage for USD6.5 Million 18
NicOx Completes Acquisition Of Eupharmed For US$8 Million 19
NicOx SA – Key Competitors 21
NicOx SA – Key Employees 22
NicOx SA – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Sep 08, 2017: Nicox first half 2017 business and financial update 24
Apr 27, 2017: Nicox first quarter 2017 business update and cash position 25
Mar 31, 2017: Nicox: Business Update and 2016 Financial Results 26
Sep 22, 2016: Nicox first half 2016 business and financial update 28
May 10, 2016: Nicox first quarter 2016 financial and business update 30
Apr 15, 2016: Nicox: 2015 Financial Results and Business Update 31
Feb 25, 2016: Nicox reports strong revenue growth in 2015 and provides corporate update 33
Corporate Communications 34
May 17, 2017: Mrs. Lauren P. Silvernail appointed to Nicox Board of Directors 34
May 17, 2017: Ms. Lauren P. Silvernail appointed to Nicox Board of Directors 35
Other Significant Developments 36
Nov 03, 2017: Nicox Highlights VYZULTA approval, Latest Corporate and Financial Developments, and Upcoming Pipeline Initiatives 36
Oct 24, 2017: Nicox Provides Third Quarter 2017 Business Update and Cash Position 38
Sep 08, 2017: Nicox first half 2017 business and financial update 40
Oct 11, 2016: Nicox third quarter 2016 business update and cash position 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
NicOx SA, Medical Equipment, Key Facts, 2016 2
NicOx SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NicOx SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NicOx SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NicOx SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NicOx SA, Deals By Market, 2011 to YTD 2017 8
NicOx SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nicox Enters into Licensing Agreement with OptiMed for AdenoPlus and Xailin 10
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 11
Nicox and Re-Vana Therapeutics Enter into Research Agreement 12
NicOx Enters into Co-Marketing Agreement with Nitto Medic for AdenoPlus 13
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 14
NicOx Raises USD31 Million in Private Placement of Shares 15
Nicox to Raise USD20 Million in Private Placement of Shares 16
NicOx Acquires Aciex Therapeutics 17
NicOx Acquires Doliage for USD6.5 Million 18
NicOx Completes Acquisition Of Eupharmed For US$8 Million 19
NicOx SA, Key Competitors 21
NicOx SA, Key Employees 22
NicOx SA, Subsidiaries 23

★海外企業調査レポート[NicOx SA (COX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AF AB (AF B)-エネルギー分野:企業M&A・提携分析
    Summary AF AB is an engineering and consulting company. It offers various services such as product development and IT support to sectors including automotive, telecom, defense and life sciences. The company also provides services such as communications systems management, development of customized b …
  • Cognoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cognoptix Inc (Cognoptix), formerly Neuroptix Corp is a privately held medical technology company that develops and offers eye-scanning test for the early detection and diagnosis of Alzheimer’s disease. The company develops technology, which is used to detect the presence of Alzheimer’s rela …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …
  • Energy Resources of Australia Ltd (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Rollprint Packaging Products Inc.:企業の戦略・SWOT・財務情報
    Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • EMC Insurance Group Inc.:企業の戦略・SWOT・財務情報
    EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report Summary EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Godrej Agrovet Limited (GODREJAGRO):企業の財務・戦略的SWOT分析
    Godrej Agrovet Limited (GODREJAGRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Codan Radio Communications:企業の戦略・SWOT・財務情報
    Codan Radio Communications - Strategy, SWOT and Corporate Finance Report Summary Codan Radio Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • OpGen Inc (OPGN):製品パイプライン分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Tetra Tech. Inc:企業のM&A・事業提携・投資動向
    Tetra Tech. Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tetra Tech. Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Gedeon Richter Plc:企業の戦略・SWOT・財務分析
    Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report Summary Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Eindec Corporation Ltd (42Z):企業の財務・戦略的SWOT分析
    Eindec Corporation Ltd (42Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Seiko Optical Products Co Ltd:企業の戦略的SWOT分析
    Seiko Optical Products Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Aker ASA (AKER):石油・ガス:M&Aディール及び事業提携情報
    Summary Aker ASA (Aker) is an industrial investment company that operates through Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor ASA, Ocean Yield …
  • Boyd Gaming Corporation:企業のM&A・事業提携・投資動向
    Boyd Gaming Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boyd Gaming Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • XCR Diagnostics Inc:企業の製品パイプライン分析
    Summary XCR Diagnostics Inc (XCR Diagnostics) is a designer and developer of real-time PCR assays. The company’s products include brucella abortus detection assay, brucella ovis detection assay and custom real time PCR master mix. It offers services such as assay design services, assay design and co …
  • PHX Minerals Inc (PHX):企業の財務・戦略的SWOT分析
    PHX Minerals Inc (PHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務情報
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vertu Motors Plc:企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆